Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 6/20 | 0.38 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.36 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.35 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.33 |
| ▸ | KDR | P35968 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.32 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.32 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.32 |
| ▸ | MKNK1 | Q9BUB5 | 1/20 | 0.32 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.32 |
| ▸ | WNT3A | P56704 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15977835 | 0.97 | PDK2 (0.40) | PDK2PIK3CAIMPDH2MAPK10PDPK1 | |
| SCHEMBL15977830 | 0.92 | PDK2 (0.43) | PDK2PIK3CAMAPK10CYP11B1CYP11B2 | |
| SCHEMBL13487896 | 0.90 | PDK2 (0.46) | PDK2PIK3CAIMPDH2MKNK1HSD17B1 | |
| SCHEMBL15977827 | 0.90 | PDK2 (0.45) | PDK2PIK3CAMAPK10KDRCYP11B1 | |
| SCHEMBL15977521 | 0.89 | PDK2 (0.45) | PDK2PIK3CAMAPK10KDRCYP11B1 | |
| SCHEMBL15977733 | 0.89 | PDK2 (0.43) | PDK2KDRWNT3A | |
| SCHEMBL13158893 | 0.88 | PDK2 (0.37) | PDK2 | |
| SCHEMBL26161138 | 0.88 | PDK2 (0.37) | PDK2HSD17B1HSD17B2 | |
| SCHEMBL20176477 | 0.87 | PDK2 (0.37) | PDK2HSD17B1HSD17B2 | |
| SCHEMBL13488126 | 0.87 | PDK2 (0.46) | PDK2PIK3CAIMPDH2MKNK1HSD17B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
| US-9559311-B2 | Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-31 | — | — | US | disclosed |
| US-9559311-B2 | Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-31 | — | — | US | disclosed |
| US-20140239273-A1 | ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-28 | — | — | US | disclosed |
| US-20140239273-A1 | ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | PIEZO1, TMEM109, SLC39A14 | PDK2 924/4885PIK3CA 2722/4885IMPDH2 3647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.